Nature’s Sunshine Products, Inc. (NASDAQ:NATR – Get Free Report) EVP Daniel Norman sold 8,884 shares of Nature’s Sunshine Products stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $20.46, for a total value of $181,766.64. Following the completion of the sale, the executive vice president owned 66,636 shares in the company, valued at approximately $1,363,372.56. This trade represents a 11.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
Nature’s Sunshine Products Stock Down 4.6%
NATR stock traded down $0.96 on Wednesday, reaching $19.86. 83,154 shares of the company’s stock were exchanged, compared to its average volume of 79,353. The stock has a fifty day moving average of $15.92 and a 200-day moving average of $15.47. The firm has a market cap of $347.47 million, a PE ratio of 26.84 and a beta of 1.09. Nature’s Sunshine Products, Inc. has a twelve month low of $11.01 and a twelve month high of $21.64.
Nature’s Sunshine Products (NASDAQ:NATR – Get Free Report) last posted its quarterly earnings results on Thursday, November 6th. The company reported $0.36 earnings per share for the quarter, topping analysts’ consensus estimates of $0.18 by $0.18. Nature’s Sunshine Products had a net margin of 3.06% and a return on equity of 10.19%. The business had revenue of $88.99 million for the quarter, compared to analysts’ expectations of $119.39 million. Nature’s Sunshine Products has set its FY 2025 guidance at EPS.
Institutional Investors Weigh In On Nature’s Sunshine Products
Analysts Set New Price Targets
A number of equities research analysts have recently issued reports on NATR shares. Weiss Ratings reiterated a “hold (c)” rating on shares of Nature’s Sunshine Products in a research report on Wednesday, October 8th. DA Davidson lifted their price objective on Nature’s Sunshine Products from $21.00 to $23.00 and gave the company a “buy” rating in a research report on Monday, November 10th. Finally, Canaccord Genuity Group upped their price target on shares of Nature’s Sunshine Products from $21.00 to $22.00 and gave the stock a “buy” rating in a research report on Friday, August 1st. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Nature’s Sunshine Products presently has an average rating of “Moderate Buy” and a consensus target price of $22.50.
View Our Latest Research Report on Nature’s Sunshine Products
Nature’s Sunshine Products Company Profile
Nature’s Sunshine Products, Inc, a natural health and wellness company, manufactures and sells nutritional and personal care products in Asia, Europe, North America, Latin America, and internationally. It offers general health products related to blood sugar support, bone health, cellular health, cognitive function, joint health, mood, sexual health, sleep, sports and energy, and vision.
Further Reading
- Five stocks we like better than Nature’s Sunshine Products
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- onsemi Places a $6 Billion Bet on Its Own Stock
- Pros And Cons Of Monthly Dividend Stocks
- HIMS Has Been a Roller Coaster Ride. Should Investors Hop On?
- 3 REITs to Buy and Hold for the Long Term
- End the Year Strong With These 3 Comeback Champions
Receive News & Ratings for Nature's Sunshine Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nature's Sunshine Products and related companies with MarketBeat.com's FREE daily email newsletter.
